RTI Surgical (RTIX) Given Daily Media Impact Rating of 0.03

News articles about RTI Surgical (NASDAQ:RTIX) have trended somewhat positive recently, according to Accern Sentiment Analysis. Accern rates the sentiment of press coverage by monitoring more than twenty million blog and news sources. Accern ranks coverage of public companies on a scale of -1 to 1, with scores nearest to one being the most favorable. RTI Surgical earned a daily sentiment score of 0.03 on Accern’s scale. Accern also assigned news stories about the medical equipment provider an impact score of 46.8065423365699 out of 100, meaning that recent press coverage is somewhat unlikely to have an impact on the company’s share price in the next few days.

These are some of the news stories that may have effected Accern Sentiment’s scoring:

Several equities research analysts recently issued reports on RTIX shares. BidaskClub downgraded RTI Surgical from a “buy” rating to a “hold” rating in a research note on Tuesday, August 8th. Zacks Investment Research downgraded RTI Surgical from a “hold” rating to a “sell” rating in a research note on Thursday, October 5th.

Shares of RTI Surgical (NASDAQ:RTIX) traded down $0.08 during trading on Monday, reaching $4.72. The company had a trading volume of 90,000 shares, compared to its average volume of 187,961. RTI Surgical has a 1 year low of $2.90 and a 1 year high of $6.00. The company has a debt-to-equity ratio of 0.25, a quick ratio of 1.21 and a current ratio of 3.34. The stock has a market cap of $287.43, a P/E ratio of 118.13, a P/E/G ratio of 6.30 and a beta of 1.76.

RTI Surgical (NASDAQ:RTIX) last posted its quarterly earnings results on Thursday, November 2nd. The medical equipment provider reported $0.01 earnings per share for the quarter, hitting the Zacks’ consensus estimate of $0.01. RTI Surgical had a return on equity of 2.29% and a net margin of 1.01%. The company had revenue of $66.69 million during the quarter, compared to the consensus estimate of $65.63 million. RTI Surgical’s revenue for the quarter was up .2% compared to the same quarter last year. research analysts forecast that RTI Surgical will post 0.05 earnings per share for the current year.

COPYRIGHT VIOLATION NOTICE: “RTI Surgical (RTIX) Given Daily Media Impact Rating of 0.03” was first published by Community Financial News and is owned by of Community Financial News. If you are reading this piece of content on another publication, it was illegally copied and reposted in violation of U.S. and international copyright & trademark laws. The legal version of this piece of content can be accessed at https://www.com-unik.info/2017/12/04/rti-surgical-rtix-given-daily-media-impact-rating-of-0-03.html.

RTI Surgical Company Profile

RTI Surgical, Inc is engaged in producing orthopedic and other surgical implants that repair and promote the natural healing of human bone and other human tissues. The Company uses natural tissues, metals and synthetics process to produce its products. The Company’s business primarily consists of six categories, such as spine, sports medicine, ortho fixation, bone graft substitutes and general orthopedic (BGS and general orthopedic), dental and surgical specialties.

Insider Buying and Selling by Quarter for RTI Surgical (NASDAQ:RTIX)

What are top analysts saying about RTI Surgical Inc? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for RTI Surgical Inc and related companies.


Leave a Reply

share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit